LOINC
Version 2.70

97656-3Hereditary cancer multigene analysis in Blood or Tissue by Molecular genetics methodActive

Term Description

Multigene testing for heritable germline mutations in genes associated with cancer in various organ systems, including breast and gynecologic (breast, ovarian, uterine), gastrointestinal (colorectal, gastric, pancreatic), endocrine (thyroid, paraganglioma/pheochromocytoma, parathyroid, pituitary), genitourinary (renal/urinary tract, prostate), skin (melanoma, basal cell carcinoma), brain/nervous system, and bone/soft tissue (sarcoma) & blood (myelodysplastic syndrome/leukemia). Testing is performed to confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variants may also used to inform at-risk relatives. Approximately 5-10 percent of cancers are thought to be hereditary.[PMID: 15637391] This test is not appropriate for the detection of somatic mutations in tumor tissue since it is focused on heritable germline mutations.
Source: Regenstrief LOINC

Fully-Specified Name

Component
Hereditary cancer multigene analysis
Property
Find
Time
Pt
System
Bld/Tiss
Scale
Doc
Method
Molgen

Additional Names

Short Name
Hereditary Cancer Multigene Anl Bld/T
Display Name
Hereditary cancer multigene analysis Molgen Doc (Bld/Tiss)
Consumer Name Alpha
Hereditary cancer multigene analysis, Blood or tissue specimen

Basic Attributes

Class
MOLPATH
Type
Laboratory
First Released
Version 2.70
Last Updated
Version 2.70
Order vs. Observation
Both

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=97656-3